INTRA-CELLULAR THERAPIES INC (ITCI) Stock Analyst Ratings
NASDAQ:ITCI - Nasdaq - US46116X1019 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 71% to ITCI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 133.34. This target is 1.6% above the current price.
ITCI was analyzed by 19 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about ITCI.
In the previous month the buy percentage consensus was at a similar level.
ITCI was analyzed by 19 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-24 | Mizuho | Downgrade | Outperform -> Neutral |
| 2025-02-21 | Needham | Reiterate | Hold -> Hold |
| 2025-01-31 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2025-01-22 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2025-01-14 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2025-01-13 | Needham | Downgrade | Buy -> Hold |
| 2024-11-04 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-10-31 | Needham | Reiterate | Buy -> Buy |
| 2024-10-30 | Needham | Reiterate | Buy -> Buy |
| 2024-10-11 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-10-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-09-20 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-16 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-06 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2024-08-21 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-08-08 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-08-08 | UBS | Maintains | Neutral -> Neutral |
| 2024-08-08 | Needham | Reiterate | Buy -> Buy |
| 2024-08-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-08-08 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-08-07 | Needham | Reiterate | Buy -> Buy |
| 2024-07-22 | Needham | Maintains | Buy -> Buy |
| 2024-06-25 | UBS | Downgrade | Buy -> Neutral |
| 2024-06-25 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-06-21 | Mizuho | Maintains | Buy -> Buy |
| 2024-06-20 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-06-18 | Needham | Maintains | Buy -> Buy |
| 2024-06-14 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-06-12 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-05-08 | Needham | Reiterate | Buy -> Buy |